Patent details

EP3181587 Title: ANTI-HUMAN IL-17 MONOCLONAL ANTIBODY AND USE THEREOF

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3181587
WO Application Number:
CN2016074805
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP16758458.0
WO Publication Number:
WO2016138842
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
China (CN)
Publications:

Dates

Filing date:
29/02/2016
Grant date:
28/08/2019
EP Publication Date:
21/06/2017
WO Publication Date:
09/09/2016
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
28/08/2019
EP B1 Publication Date:
28/08/2019
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
28/02/2036
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
28/08/2019
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
28/08/2019
 
 

 

Name:
Beijing Bettermab Biotechnology Co., Ltd
Address:
Unit 7-2C083 No. 15 Jia Jia Hua Yuan Fengtai District, Beijing, China (CN)

From:
28/08/2019
 
 

 

Name:
Beijing Wisdomab Biotechnology Co., Ltd
Address:
Unit A3-501 No. 88 Kechuang 6th Street Beijing Economic and Technological Development Area, Beijing, China (CN)

From:
28/08/2019
 
 

 

Name:
Genrix(Shanghai) Biopharmaceutical Co., Ltd.
Address:
Room 502 Building No. 8 No. 200 Niudun Road Zhang Jiang High-Tech Park Pudong District, Shanghai 201203, China (CN)

From:
28/08/2019
 
 

 

Name:
Chongqing Genrix Biopharmaceutial Co., Ltd.
Address:
Floor 21 Building No.7 Jinyuan Road Jiangbei District, Chongqing 400020, China (CN)

Inventor

1

Name:
LIU, Zhigang
Address:
Beijing, China (CN)

2

Name:
SHEN, Shijie
Address:
Beijing, China (CN)

3

Name:
LIU, Yulan
Address:
Beijing, China (CN)

4

Name:
GUO, Jingjing
Address:
Beijing, China (CN)

5

Name:
HAO, Xiaobo
Address:
Beijing, China (CN)

Priority

Priority Patent Number:
201510097117
Priority Date:
05/03/2015
Priority Country:
China (CN)

Classification

IPC or IDT classification:
A61K 39/395; A61P 37/02; C07K 16/24;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
53/19
Publication date:
01/01/2020
Description:
Lapse or annulment

2

Bulletin Heading:
EP2
Journal edition number:
35/19
Publication date:
28/08/2019
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201935
Publication date:
28/08/2019
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type